Identifying blood markers that predict heart failure complications
Blood Biomarkers Associated with Adverse Outcomes in Heart Failure
['FUNDING_R21'] · STATE UNIVERSITY NEW YORK STONY BROOK · NIH-11043732
This study is looking at certain blood tests that might help doctors find out which heart failure patients are more likely to have problems with their heart and kidneys, so they can make better treatment decisions for everyone, whether their heart function is strong or weak.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STATE UNIVERSITY NEW YORK STONY BROOK (nih funded) |
| Locations | 1 site (STONY BROOK, UNITED STATES) |
| Trial ID | NIH-11043732 on ClinicalTrials.gov |
What this research studies
This research investigates blood biomarkers that can help identify patients with heart failure who are at increased risk for adverse cardiovascular and kidney outcomes. It focuses on patients with both preserved and reduced ejection fraction heart failure, aiming to determine which biomarkers are most effective in predicting declines in kidney function and related complications. By analyzing various biomarkers, including serum creatinine and cystatin C, the study seeks to improve prognostication and clinical decision-making for patients with heart failure.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with heart failure, particularly those with preserved or reduced ejection fraction.
Not a fit: Patients without heart failure or those with other unrelated cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification of patients at risk for serious complications, allowing for timely interventions and improved management of heart failure.
How similar studies have performed: Previous research has shown promise in using blood biomarkers to predict outcomes in heart failure, suggesting that this approach may yield valuable insights.
Where this research is happening
STONY BROOK, UNITED STATES
- STATE UNIVERSITY NEW YORK STONY BROOK — STONY BROOK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HEDAYATI, SUSAN — STATE UNIVERSITY NEW YORK STONY BROOK
- Study coordinator: HEDAYATI, SUSAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.